18-23544981-C-G

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 3P and 20B. PM1PP2BP4_StrongBP6_Very_StrongBA1

The NM_000271.5(NPC1):​c.1926G>C​(p.Met642Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.687 in 1,530,962 control chromosomes in the GnomAD database, including 374,159 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M642T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.74 ( 40038 hom., cov: 22)
Exomes 𝑓: 0.68 ( 334121 hom. )

Consequence

NPC1
NM_000271.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: 2.90

Publications

73 publications found
Variant links:
Genes affected
NPC1 (HGNC:7897): (NPC intracellular cholesterol transporter 1) This gene encodes a large protein that resides in the limiting membrane of endosomes and lysosomes and mediates intracellular cholesterol trafficking via binding of cholesterol to its N-terminal domain. It is predicted to have a cytoplasmic C-terminus, 13 transmembrane domains, and 3 large loops in the lumen of the endosome - the last loop being at the N-terminus. This protein transports low-density lipoproteins to late endosomal/lysosomal compartments where they are hydrolized and released as free cholesterol. Defects in this gene cause Niemann-Pick type C disease, a rare autosomal recessive neurodegenerative disorder characterized by over accumulation of cholesterol and glycosphingolipids in late endosomal/lysosomal compartments.[provided by RefSeq, Aug 2009]
NPC1 Gene-Disease associations (from GenCC):
  • Niemann-Pick disease, type C1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Myriad Women’s Health
  • Niemann-Pick disease type C, adult neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, juvenile neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, late infantile neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, severe early infantile neurologic onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Niemann-Pick disease type C, severe perinatal form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 4 uncertain in NM_000271.5
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 171 curated pathogenic missense variants (we use a threshold of 10). The gene has 18 curated benign missense variants. Gene score misZ: 1.0917 (below the threshold of 3.09). Trascript score misZ: 1.706 (below the threshold of 3.09). GenCC associations: The gene is linked to Niemann-Pick disease, type C1, Niemann-Pick disease type C, severe early infantile neurologic onset, Niemann-Pick disease type C, late infantile neurologic onset, Niemann-Pick disease type C, adult neurologic onset, Niemann-Pick disease type C, juvenile neurologic onset, Niemann-Pick disease type C, severe perinatal form.
BP4
Computational evidence support a benign effect (MetaRNN=1.0263868E-6).
BP6
Variant 18-23544981-C-G is Benign according to our data. Variant chr18-23544981-C-G is described in ClinVar as Benign. ClinVar VariationId is 92701.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.901 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPC1NM_000271.5 linkc.1926G>C p.Met642Ile missense_variant Exon 12 of 25 ENST00000269228.10 NP_000262.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPC1ENST00000269228.10 linkc.1926G>C p.Met642Ile missense_variant Exon 12 of 25 1 NM_000271.5 ENSP00000269228.4 O15118-1
NPC1ENST00000591051.1 linkc.1002G>C p.Met334Ile missense_variant Exon 5 of 18 2 ENSP00000467636.1 K7EQ23
NPC1ENST00000540608.5 linkn.1840G>C non_coding_transcript_exon_variant Exon 10 of 16 2

Frequencies

GnomAD3 genomes
AF:
0.740
AC:
104617
AN:
141462
Hom.:
39989
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.909
Gnomad AMI
AF:
0.719
Gnomad AMR
AF:
0.744
Gnomad ASJ
AF:
0.579
Gnomad EAS
AF:
0.923
Gnomad SAS
AF:
0.761
Gnomad FIN
AF:
0.604
Gnomad MID
AF:
0.644
Gnomad NFE
AF:
0.650
Gnomad OTH
AF:
0.698
GnomAD2 exomes
AF:
0.729
AC:
174136
AN:
238838
AF XY:
0.720
show subpopulations
Gnomad AFR exome
AF:
0.924
Gnomad AMR exome
AF:
0.828
Gnomad ASJ exome
AF:
0.578
Gnomad EAS exome
AF:
0.935
Gnomad FIN exome
AF:
0.659
Gnomad NFE exome
AF:
0.653
Gnomad OTH exome
AF:
0.693
GnomAD4 exome
AF:
0.682
AC:
947164
AN:
1389384
Hom.:
334121
Cov.:
33
AF XY:
0.682
AC XY:
470282
AN XY:
689718
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.921
AC:
30440
AN:
33068
American (AMR)
AF:
0.821
AC:
34961
AN:
42608
Ashkenazi Jewish (ASJ)
AF:
0.575
AC:
14163
AN:
24622
East Asian (EAS)
AF:
0.944
AC:
36721
AN:
38914
South Asian (SAS)
AF:
0.768
AC:
62468
AN:
81360
European-Finnish (FIN)
AF:
0.660
AC:
33153
AN:
50202
Middle Eastern (MID)
AF:
0.631
AC:
3514
AN:
5570
European-Non Finnish (NFE)
AF:
0.655
AC:
691882
AN:
1055624
Other (OTH)
AF:
0.694
AC:
39862
AN:
57416
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.367
Heterozygous variant carriers
0
10625
21249
31874
42498
53123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18424
36848
55272
73696
92120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.740
AC:
104728
AN:
141578
Hom.:
40038
Cov.:
22
AF XY:
0.739
AC XY:
50240
AN XY:
67968
show subpopulations
African (AFR)
AF:
0.909
AC:
35552
AN:
39118
American (AMR)
AF:
0.744
AC:
9866
AN:
13256
Ashkenazi Jewish (ASJ)
AF:
0.579
AC:
1960
AN:
3386
East Asian (EAS)
AF:
0.922
AC:
4390
AN:
4762
South Asian (SAS)
AF:
0.760
AC:
3325
AN:
4374
European-Finnish (FIN)
AF:
0.604
AC:
4897
AN:
8104
Middle Eastern (MID)
AF:
0.633
AC:
171
AN:
270
European-Non Finnish (NFE)
AF:
0.650
AC:
42571
AN:
65482
Other (OTH)
AF:
0.701
AC:
1369
AN:
1954
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.411
Heterozygous variant carriers
0
980
1961
2941
3922
4902
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
782
1564
2346
3128
3910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.659
Hom.:
22488
Bravo
AF:
0.763
TwinsUK
AF:
0.655
AC:
2427
ALSPAC
AF:
0.645
AC:
2484
ESP6500AA
AF:
0.910
AC:
4008
ESP6500EA
AF:
0.645
AC:
5547
ExAC
AF:
0.718
AC:
87148
Asia WGS
AF:
0.844
AC:
2934
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:17
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Niemann-Pick disease, type C1 Benign:8
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 11, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 22, 2016
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:6
Nov 21, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23153210) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 23, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
16
DANN
Benign
0.77
DEOGEN2
Benign
0.24
T
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.29
T
MetaRNN
Benign
0.0000010
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-2.1
N
PhyloP100
2.9
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
1.6
N
REVEL
Benign
0.26
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.10
MutPred
0.24
Gain of MoRF binding (P = 0.1764);
MPC
0.28
ClinPred
0.0077
T
GERP RS
5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.15
gMVP
0.19
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1788799; hg19: chr18-21124945; COSMIC: COSV99342159; COSMIC: COSV99342159; API